loading...| Preferred Name | Anti-Arrhythmia Agents | |
| Synonyms |
Antiarrhythmia Agents Antiarrhythmic drug Anti-Arrhythmics Antiarrhythmic Drugs anti-arrhythimia agents Antiarrhythmic Antiarrhythmic agent Anti-Arrhythmia Drugs Antiarrhythmia Drugs Cardiac Depressant antiarrhythmia Anti-arrhythmic Agent ANTIARRHYTHMICS antiarrhythmic agents |
|
| Definitions |
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (source : MSH) |
|
| ID |
http://doe-generated-ontology.com/OntoAD#C0003195 |
|
| altLabel |
Antiarrhythmia Agents Antiarrhythmic drug Anti-Arrhythmics Antiarrhythmic Drugs anti-arrhythimia agents Antiarrhythmic Antiarrhythmic agent Anti-Arrhythmia Drugs Antiarrhythmia Drugs Cardiac Depressant antiarrhythmia Anti-arrhythmic Agent ANTIARRHYTHMICS antiarrhythmic agents |
|
| definition |
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (source : MSH) |
|
| hiddenLabel |
Anti-ArrhythmiaAgents |
|
| may_prevent | ||
| prefixIRI |
OntoAD:C0003195 |
|
| prefLabel |
Anti-Arrhythmia Agents |
|
| subClassOf |